Replies to post #11621 on Generex Biotechnology Corp. (fka GNBTQ)

[Jimmy Joe]

Generex has a huge head start already funded by the Chinese. If the vaccine works the upside is huge. They will be able to test in China with less restrictions vs the FDA.

True, but their li-Key vaccine for triple negative breast cancer is already robust and now in phase trials coupled with Merck's Keytruda.
Upside is still large even without COVID-19 vaccine entry.
COVID-19 may add more credibility to their technology should they accomplish what they set out to do.... create a vaccine for COVID-19. Somewhat validating what they have to the world at large. And you are right, that is huge.